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Abstract 
Background . The new diagnostic criteria of gestational diabetes mellitus (GDM）ラwhichwas proposed by 
the International Association of Diabetes and Pregnancy Study Groups in 2010ラwasrecently accepted by 
Japan. Thereforeラthefrequency of GDM isfour times higher than previously recorded. This means that 
GDM has become a more clinically important disease. This study aimed to assess how the number of 
patients with GDM and its complications have changed after adoption of the new criteria. 
Methods : A total of 3ふ10pregnant women in the Japan Assessment of GDM Screening Trial and 
Okayama University Hospital were included. We analyzed the prevalence of GDM and its complications 
using the old and new criteria. 
Results: The prevalence of perinatal outcomes was increased by adopting the new criteria. There were 
many important perinatal complications in the additional new GDM criteriaラandtherefore patients with 
mild GDMラlikeone point disorder patientsラ shouldhave careful intervention. Admission to the neonatal 
intensive care unit was significantly increased (p=0.01) according to the new GDM criteria because the 
old criteria are stricter than the new criteria. GDM patients with obesity (BMI三25kg/m2) had a high 
frequency of perinatal complications that may require active intervention and strict follow-up. 
Conclusions : Because the new criteria of GDM greatly affect perinatal complicationsラ interventionof 
GDM from an early stage and strict follow-up (especially GDM with obesity) are important for reducing 
complicationsラanddiabetes and metabolic syndrome of the mother and child. 
Key words New GDM criteria, perinatal complicationsラobesityラ75・goral glucose tolerance test 
Introduction 
Diabetes mellitus (DM) has been increasing worldwideラ especiallyin developed countries because of 
people’s diet [l]. DM inJapan is also increasing every year. In 2007 approximately 22ラ100ρ00patients in 
Japan had DM or a propensity to develop DM. DM and gestational DM (GDM) are common diseases 
during pregnancy. Gestational age is also related to glucose intolerance [2]. DM and GDM during 
pregnancy may result in many maternal and neonatal complicationsラ suchas macrosomiaラ fetal
malformationsラneonatalhypoglycemiaラhyperbilimbinemia,and hypertension. Therefo民 DMandGDM
are important diseases that need to be managed during pregnancy. Andラthenumber of patients with DM 
needs to be reduced. Identifying GDM isa good method of determining the potential for DM because 
mild glucose intolerance during pregnancy is easily observed. The current definition of GDM, as any DM 
found during pregnancyラwasadopted 26 years ago. This definition needs to be changed to fit the current 
conditions. Criteria should be divided ben万eenGDM and DM. Therefore we changed the definition of the 
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GDM criteria as the onset of any glucose intolerance during pregnancyラ exceptfor overt diabetes in 
pregnancy based on an international consensus. 
The International Association of Diabetes and Pregnancy Study Groups (IADPSG) published new 
universal diagnostic criteria based on the Hyperglycemia and Adverse Pregnancy Outcomes (HAPO) 
study in 2010 [3ラ4].In July 2010ラtheJapan Society of Obstetrics and Gynecology (JSOG) accepted the 
new diagnostic criteria of gestational diabetes mellitus (GDM）ラ whichwere proposed by the IADPSG. 
JSOG changed the cutoff of the glucose value in each hour in the 75・goral glucose tolerance test (OGTT) 
and began to diagnose GDM by using an abnormal glucose value at only one time point (instead of two 
time points) with the new diagnostic criteria. Moreoverラ weadopted the concept of overt diabetes in 
pregnancy. We found that the frequency of GDM rapidly increased because of the new criteria and GDM 
became an important clinical disease. 
Materials and Methods 
The current study included patients from the Japan Assessment of GDM Screening (JAGS) Trial (there 
were 3527 patientsラincludinghealthy patients in 28 hospitals from 2001 to 2011) and 83 GDM patients 
from Okayama University hospital between 2004 and 2010ラ witha total of 3610 patients. In the JAGS 
trialラalpatients had a 7 5・gOGTT. We compared perina凶 outcomesof the old and new GDM criteria by 
a retrospective case-control study. 
Glucose values were measured three times (fastingラ 1h after.ラ and2 h after) in the 75・gOGTT. The old 
GDM criteria defined abnormal glucose values at two and three time points in the 75・gOGTT. The cutoff 
of glucose values for fasting was三100mg/dlラ 1h after fasting was三180mg/dl and 2 h after fasting was 
三150mg/dl. All time points of glucose intolerance during pregnancy were included in the old criteria. The 
new GDM criteria were changed and defined abnormal glucose values at only one time point in the 75・g
OGTT. The cutoff of glucose values for fasting was三92mg/dlラ1h after fasting was三180mg/dlラand2 h 
after fasting三153mg/dl. Moreoverラtheconcept of overt diabetes in pregnancy was adopted. 
There were 2022 patients who had a 75・gOGTT in the first trimester. A total of 2832 patients had a 75・g
OGTT in the second trimester (24・28weeks of gestation）ラ andthese patients had at least one time point 
with an abnormal glucose value. However.ラ whetherthe patients had treatment is unknown. Adverse 
perinatal outcomes were respiratory problemsラ macrosomiaラ fetalmalformations, hyperbilimbinemiaラ
neonatal hypoglycemia, preeclampsiaラshoulderdystociaラandprimary cesarean section. Additionallyラwe
surveyed adverse perinatal outcomes of an additional 341 GDM patients because of the new GDM criteria. 
The additional GDM define the patients are in the new GDM criteria but they are not in the old GDM 
criteria. 
Microsoft Excel 2010 for Windows 7 was used for statistical analysis. Statistical significance for perinatal 
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outcomes was determined using the Mann-Whitney U test. Statistical significance of complications 
between the new GDM and the old GDMラandbetween body mass index (BMl）三25kg/m2 and BMI <25 
kg/m2ラwasdetermined by the x2 test. Values ofp<0.05 we民 consideredsignificant. 
Results 
The maternal and perinatal characteristics of the 3610 women who agreed to participate in this study are 
shown in Table 1. BMl of the women diagnosed by old GDM criteria was significantly larger than that of 
the women diagnosed by new GDM criteria (p=0.03). There was no significant difference in the mean 
gestational age in weeksラ 75・gOGTT results ,birth weightラ deliveryweekラ andthe rate of preterm 
deliveries between both criteria. 
The prevalence of GDM increased from 83/2839 patients (2.92%) to (363/2839patients) 12.08% by 
adopting the new criteria in the data of the JAGS trial. Unique complications of GDM were also increased 
according to the new criteria of GDM (Table 2). Admission to the neonatal intensive care unit (NICU) 
occurred in more (22/135：ラ 16.3%)patients according to the old criteria for GDM compared with that in 
patients according to the new criteria for GDM (44/491; 9.0%ラp<0.05).Howeverラinpatients with other 
complications (i.e.ラ respiratory problems of newbornsラ macrosomia, fetal malformationsラ
hyperbilimbinemiaラ neonatalhypoglycemiaラ shoulderdystociaラ andpregnancy induced hypertension 
[PIH］）ラ thenumber of complications appeared to be increased according to the new criteria, but there 
were no statistical difference between the two groups. The rate of primary cesarean delivery also 
increased from 19 to 48 patientsラwhichmeant that there was an increase by 2.5 times. 4 patients were 
IUFD in the first trimester (3for the additional GDM). l patient was induced abortion in the second 
trimester to the old criteria for GDM. There is not neonatal death. 
We also analyzed the difference in perinatal complications according to the new GDM criteriaラ which
were diagnosed by one, twoラandthree time points that had abnormal glucose values in the 75・gOGTT. 
There were no differences in perinatal complications between patients who had one time point with an 
abnormal glucose value and those who had two time points with an abnormal glucose value for GDM. 
Patients who had on巳timepoint with an abnormal glucose value in the 75・gOGTT had as many 
complications as those who had two r three time points with an abnormal glucose value (Table 3). 
The additional new GDM patients also had many perinatal complicationsラwhichwere sometimes severe 
(Table 4). For exampleラtherewere four cases of macrosomia in patients who had one time point with an 
abnormal glucose value in the second trimesterラalthoughwe could not find this complication according to 
the old GDM criteria. Six patients (three patients had one time point with an abnormal glucose value in 
the first trimester and the other three patients had on巳timepoint with an abnormal glucose value in the 
second trimester) had neonatal hypoglycemiaラincludingone patient with hyperbilimbinemia and the birth 
weight was greater than 3500 g. Fetal malformations appeared in six patients. Three of these patients had 
one time point with an abnormal glucose value in the first trimester and the other three patients had one 
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time point with an abnormal glucose value in the second trimester. Two patients had cardiovascular 
diseaseラtwopatients had urinary diseaseラandthe other two patients were unknown. Moreoverラ23of the 
additional new GDM patients (first trimester: nine patients; second trimester: 1 patients; both trimesters: 
three patients) had PIH. Seven patients had early onset PIH and 16 patients had late onset PIH. Two of 
these patients were operated on with emergency cesarean section because of severe superimposed 
preeclampsia. Ten of these patients had obesity (BMI三25kg/m2). These results suggest that PIHラGDMラ
and obesity may be related to each other. 
There was a high incidence of GDM in PIH patients who had a BMI三25kg/m2・ラ thereforeラ we
investigated the occurrence of perinatal complications (Table 5). A total of 82 patients (16.7%) had GDM 
according to the new GDM criteria (n=491) and had a BMI of greater than 25 kg/m2. A total of 409 of 491 
(83.3%) patients did not have obesity. The proportions of patients with perinatal complications who had a 
BMI greater than 25 kg/m2 and less than 25 kg/m2 were 15.8% and 7.6% for admission to the NICUラ
7.3% and 1.5% for fetal malformationsラ 1.2%and 0% for hypertrophic cardiomyopathyラ and14.9% and 
5.9% for PIHラrespectively.Thereforeラpatientswho had a BMI greater than 25 kg/m2 had a significantly 
higher incidence of complications than those with a BMI less than 25 kg/ m2 (p<0.05). 
Discussion 
In our studyラ thefrequency of GDM has increased from 2.92% according to the old criteria to 12.08% 
according to the new criteria. Thereforeラtherewere 4.1 times as many patients according to the new 
GDM by adopting new diagnostic criteria for GDM in the JAGS trial. Howeverラthisfrequency is based 
on the case where al patients had a 75・gOGTT. For those patients who had positive signs in screening 
(for exampleラa50・gglucose challenge test）ラ江theyhad had a 7 5・gOGTT insteadラthisfrequency would 
be approximately 1 % [ 5]. 
The number of patients with a given complication increased overall when the new GDM criteria were 
adopted. Admission to the NICU was only significant according to the new GDM criteria, because the old 
criteria were severe. However.ラ thereare many perinatal complications in mild GDM, suggesting that 
identifying mild GDM and intervention are useful for patients. Several randomized control trials (RCTs) 
[6ラ7]have reported similar results. For exampleラmacrosomiaラwhichis unique to glucose intolerance 
according to the old GDM criteriaラwasnot found in any patientsラandaccording to the new GDM criteriaラ
it was found in five patients. Thereforeラclinicalmanagement might be inadequate for these five patients 
according to the new GDM criteria. We consider that treatment for these patients may reduce shoulder 
dystociaラ cephalopelvicdisproportion and emergency cesarean sectionラ whichare complications of 
macrosomia. A RCT reported that macrosomia is reduced by treatment for GDM [8]. Another 
retrospective case-control study reported that patients with diabetes have a higher risk of macrosomia 
than patients without diabetes [9]. Intervention is important because there are also many perinatal 
complications in the additional new GDM criteria. Blood glucose during pregnancy is also important for 
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perinatal outcome [10]. Thereforeラwecan expect to reduce several perinatal complications by monitoring 
blood glucose and active treatment of GDM. There are adverse complications of GDM through the first or 
the second trimester. We found that macrosomiaラ fetalmalformationsラ neonatalhypoglycemiaラ and
preeclampsia were present in screening of both the first and second trimesters for the additional new 
GDM criteria. Consequentlyラ GDMshould be screened for in the first and second trimesters. Screening 
for GDM is usually performed at the second trimester. Otherwiseラ somestudies indicated the first 
trimester is also important for screening [11, 12]. 
In additionラ GDMwith obesi早 whichis also related to PIHラleadsto frequent perinatal complications. 
Nilofer et al demonstrated that obesity is a significant risk factor in GDM. Additionallyラadverseperinatal 
outcomes are increased by GDM [13]. In particularラ GDMラPIHラ andobesity may be closely related and 
strongly affect maternal quality of lifeラandchildren delivered from mothers with glucose intolerance may 
have metabolic syndrome (e.g.ラDMand hypertension) later in life [14]. Thereforeラweshould carefully 
manage patients with GDM and PIHラ especiallythose with obesityラ andintervene in each patient. In 
additionラthefrequency of GDM isdi百erentbetween ethnicities. Asian women show a high percentage of 
GDM, but GDM with obesity is less common in Asians than in other races[l5]. Maternal weight gain is 
also important for obstetric and neonatal outcomes [16・18].In particularラweightgain with GDM isa high 
risk factor for perinatal complications [19]. Children whose mother has GDM may become obese [20]. 
Thereforeラwehave to carefully treat GDM patients regarding diet and weight gain during pregnancy. 
Finallyラidentifyingmild glucose intolerance due to physiological load during pregnancy could be use白l
for determining the potential for DM. Many studies have reported that GDM is associated with 
subsequent risks, such as type 2 diabetes mellitus or cardiometabolic risks [21・23].Moreoverラinoffspringラ
metabolic syndrome may occur [24]. Patients with GDM according to the new GDM criteria have 
maternal and neonatal complications similar to those according to the old GDM criteria. Thereforeラ
intervention in GDM and strict follow-up are important to reduce diabetic complications in pregnancyラ
and to reduce diabetes and metabolic syndrome in the mother and child later in life.おforeover.ラ
deter.mining mild glucose intolerance according to the new GDM criteria is medically economical. 
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All Old GDM New GDM
Gestational age
(years-old)
30.26±7.03
（16-53）
32.41±4.41
（22-41）
31.9±4.78
（16-43）
BMI(kg/m2)
21.1±14.6
（14-46.1）
23.5±6.76
（16.8-48.1）
22.3±5.93
（15-48.1）*
75gOGTT
Gestational 
Weeks(weeks)
1st 9.99±2.64 10.20±3.55 10.09±2.81
2nd 24.83±2.53 25.02±3.69 24.71 ±3.10
Birth weight (g) 3004±434 3037±488 3067±450 
Gestational age at 
delivery(wk) 
38.73±1.86 38.24±1.87 38.45±1.89
Rate of 
preterm delivery
(%)
6.69 12.12 7.84
Table 1 : Maternal and perinatal characteristics
* : P<005(old GDM VS New GDM)
Table 2 : Prevalence of perinatal and neonatal outcomes according   
to the old and the new GDM criteria 
All Old GDM ％ New GDM ％ P
All 3610 135 100 491 100 －
Admission to NICU 246 22 16.3 44 9.0 <0.05
PIH 226 12 8.9 36 7.3 N.S.
Macrosomia 30 0 0 5 1.0 N.S.
Infant weight ≧3500ｇ 316 17 12.6 52 10.6 N.S.
shoulder dystocia 5 1 0.7 2 0.4 N.S.
Respiratory problems 106 4 3.0 16 3.3 N.S.
neonatal 
hypoglycemia≦40mg/dl
57 5 3.7 14 2.9 N.S.
Hyperbilirubinemia 
T.Bil≧20mg/dl
25 2 1.5 3 0.6 N.S.
Polycythemia Ht≧65％ 76 5 3.7 18 3.7 N.S.
Fetal malformations 63 5 3.7 12 2.4 N.S.
Hypocalcemia 13 0 0 1 0.2 N.S.
Hypertrophic cardiomyopathy 2 1 0.7 1 0.2 N.S.
Primary cesarean section 348 19 14.1 48 9.8 N.S.
Selective cesarean section 152 6 4.4 17 3.5 N.S.
Emergency cesarean section 196 13 9.6 31 6.3 N.S.
Body mass index≧25 304 34 25.2 73 14.9 N.S.
Table 3 : Frequency of perinatal and neonatal complications in the 
first and second  trimesters and according to time points of abnormal 
glucose values in the 75-g OGTT with the new GDM criteria
All
New 
GDM
1st
Trimester
OGTT
1st
Trimester
OGTT
2nd
Trimester
OGTT
2nd
Trimester
OGTT
1Point ≧2Points 1Point ≧2Points
All 3610 491 180 63 179 69
Admission to NICU 246 44 16 8 8 16
PIH 226 36 12 5 17 6
Macrosomia 30 4 0 0 4 0
Shoulder dystocia 5 2 0 0 1 1
Respiratory problems 106 16 8 1 7 3
Neonatal hypoglycemia 57 14 4 7 5 2
Hyperbilirubinemia 19 3 2 1 1 1
Polycythemia 52 18 6 5 11 1
Fetal malformations 63 12 2 4 5 2
Hypocalcemia 13 1 1 0 0 0
Hypertrophic cardiomyopathy 2 1 0 1 0 1
Primary cesarean section 348 48 18 10 20 10
Additional new 
GDM
％ New GDM ％
All 341 100 491 100
Admission to NICU 20 5.8 44 9.1
PIH 23 6.7 36 7.3
Fetal malformation 4 1.2 4 0.8
Infant weight ≧3500g 40 11.7 52 10.6
shoulder dystocia 0 0 2 0.4
Respiratory problems 12 3.5 15 3.1
neonatal hypoglycemia 6 1.8 14 2.9
Hyperbilirubinemia 1 0.2 3 0.6
Polycythemia 12 3.5 18 3.7
Fetal malformations 6 1.8 12 2.4
Hypocalcemia 1 0.3 1 0.2
Body mass index≧25 42 12.3 73 14.9
Hypertrophic cardiomyopathy 0 0 1 0.2
Primary  cesarean section 33 9.7 48 9.8
Selective cesarean section 13 3.8 17 3.5
Emergency cesarean section 20 5.9 31 6.3
Table 4 : Frequencies of perinatal and neonatal complications in   
additional new GDM patients compared with those in     
all new  GDM patients
BMI＜25 BMI≧25
New 
GDM
N ％ N ％ P
New GDM all 491 409 100 82 100 －
Admission to NICU 44 31 7.6 13 15.8 ＜0.05
Macrosomia 4 3 0.7 1 1.2 N.S.
Infant weight ≧3500g 52 39 9.5 13 15.9 N.S.
Shoulder dystocia 2 1 0.2 1 1.2 N.S.
Respiratory problems 16 12 2.9 4 4.9 N.S.
Neonatal hypoglycemia 9 7 1.7 2 2.4 N.S.
Polycythemia 12 8 2.0 4 4.9 N.S.
Fetal malformations 12 6 1.5 6 7.3 ＜0.05
Hypertrophic 
cardiomyopathy
1 0 0 1 1.2 ＜0.05
Hypocalcemia 1 1 0.2 0 0 N.S.
Hyperbilirubinemia 5 4 1.0 1 1.2 N.S.
Preeclampsia 36 24 5.9 12 14.6 ＜0.05
Emergency cesarean section 31 24 5.9 7 8.5 N.S.
Selective cesarean section 17 16 3.9 1 1.2 N.S.
Table 5 : Comparison of the frequency of perinatal complications 
according to BMI in women with the new GDM criteria
